From the Department of Neuroradiology (V.M.P.), and Department of Neurology (R.S.), University Hospital of Geneva, Geneva, Switzerland; Department for Diagnostic and Interventional Neuroradiology (J.G., G.S.), and Department of Neurology (M.A.), Inselspital, University of Bern, Bern, Switzerland; Department of Neurology (A.D.), and Department of Neuroradiology (C.C.), University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; Department of Neuroradiology, CHU de Montpellier - Guy de Chauliac, Montpellier, France (A.B.); Department of Neuroradiology, Alfred Krupp Krankenhaus, Essen, Germany (R.C.); Department of Neurology, UCLA Stroke Center, CA (D.S.L.); Department of Neurology, Emory University School of Medicine, Atlanta, GA (R.G.N.); Department of Neuroradiology, University Hospital of Cologne, Cologne, Germany (T.L.); Department for Neuroradiology, University of Calgary, Foothills Medical Centre, Calgary, AB, Canada (M.G.); Department of Neurology, Klinikum Osnabrueck, Osnabrueck, Germany (M.B.); and Department of Neuroradiology, Hospital Virgen de la Arrixaca, Murcia, Spain (A.M.).
Stroke. 2013 Oct;44(10):2802-7. doi: 10.1161/STROKEAHA.113.001232. Epub 2013 Aug 1.
Mechanical thrombectomy using stent retriever devices have been advocated to increase revascularization in intracranial vessel occlusion. We present the results of a large prospective study on the use of the Solitaire Flow Restoration in patients with acute ischemic stroke.
Solitaire Flow Restoration Thrombectomy for Acute Revascularization was an international, multicenter, prospective, single-arm study of Solitaire Flow Restoration thrombectomy in patients with large vessel anterior circulation strokes treated within 8 hours of symptom onset. Strict criteria for site selection were applied. The primary end point was the revascularization rate (thrombolysis in cerebral infarction ≥2b) of the occluded vessel as determined by an independent core laboratory. The secondary end point was the rate of good functional outcome (defined as 90-day modified Rankin scale, 0-2).
A total of 202 patients were enrolled across 14 comprehensive stroke centers in Europe, Canada, and Australia. The median age was 72 years, 60% were female patients. The median National Institute of Health Stroke Scale was 17. Most proximal intracranial occlusion was the internal carotid artery in 18%, and the middle cerebral artery in 82%. Successful revascularization was achieved in 79.2% of patients. Device and procedure-related severe adverse events were found in 7.4%. Favorable neurological outcome was found in 57.9%. The mortality rate was 6.9%. Any intracranial hemorrhagic transformation was found in 18.8% of patients, 1.5% were symptomatic.
In this single-arm study, treatment with the Solitaire Flow Restoration device in intracranial anterior circulation occlusions results in high rates of revascularization, low risk of clinically relevant procedural complications, and good clinical outcomes in combination with low mortality at 90 days.
http://www.clinicaltrials.gov. Unique identifier: NCT01327989.
机械血栓切除术使用支架取栓装置已被提倡用于增加颅内血管闭塞的再通率。我们报告了一项关于 Solitaire Flow Restoration 在急性缺血性脑卒中患者中应用的大型前瞻性研究结果。
Solitaire Flow Restoration 血栓切除术用于急性血管再通是一项国际性、多中心、前瞻性、单臂研究,评估 Solitaire Flow Restoration 支架取栓术在症状发作 8 小时内治疗的大动脉前循环卒中患者中的应用。严格应用了入选标准。主要终点是闭塞血管的再通率(脑梗死溶栓分级≥2b),由独立核心实验室评估。次要终点是良好功能结局的比例(定义为 90 天改良 Rankin 量表 0-2 分)。
共纳入欧洲、加拿大和澳大利亚的 14 个综合卒中中心的 202 例患者。中位年龄为 72 岁,60%为女性患者。中位 NIHSS 评分为 17 分。最接近颅内的闭塞部位为颈内动脉 18%,大脑中动脉 82%。79.2%的患者实现了成功再通。器械和操作相关的严重不良事件发生率为 7.4%。良好的神经功能结局发生率为 57.9%。死亡率为 6.9%。任何颅内出血转化发生率为 18.8%,症状性出血转化发生率为 1.5%。
在这项单臂研究中,Solitaire Flow Restoration 装置治疗颅内前循环闭塞可实现高再通率、低临床相关操作并发症风险和良好的临床结局,90 天死亡率低。